10
report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
The Impact of Insight: Patient Preferences in Novel Screening Technologies for Cancer
Patient preferences and insights are increasingly considered throughout the medical product life cy
cle in addition to clinical outcomes.
+ Read More
report
What Can Global North Learn from Global South: Lessons from Past Pandemics and Epidemics
Written by Jacobs and FasterCures, a center of the Milken Institute, this report highlights th
e de
+ Read More
report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
+ Read More
report
Building Community-Based Infrastructure for Inclusive Research: Lessons from the Pandemic for Federal Action
COVID-19 has focused the public’s attention on the racial and ethnic disparities in health outcomes
, unequal access to health care, and some communities’ lack of trust and participation in medical research.
+ Read More
report
A Global Early Warning System for Pandemics: Mobilizing Surveillance for Emerging Pathogens
In 2020, COVID-19 caught the world by surprise—this should not have been the case. The pandemic rev
ealed significant gaps in early warning capabilities to detect and respond to emerging pathogens before they cause global harm.
+ Read More
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
report
Mapping the Journey: Building a Mutual Understanding for Health Equity in Clinical Research
If the objective of biomedical research is to spur innovation to create healthier communities, exte
nd life, and more effectively treat or cure disease, then persistent inequities run counter to that goal and create unnecessary barriers to health and wel
+ Read More